NCT00077246View on ClinicalTrials.gov

ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2008

Conditions
Lung Cancer
Interventions
DRUG

paclitaxel albumin-stabilized nanoparticle formulation

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00077246 - ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter